pCFB-EGSH Retroviral Vector
Agilent TechnologiesDose-responsive inducible mammalian expression Induction as high as 1,700 fold Tightly repressed Novel IRES site allows expression of both receptor subunits from the same CMV promoter Retroviral and plasmid gene delivery systems available Stable receptor cell lines available